Managers

New Rhein collects $47.7 mln for fund

New Rhein Healthcare Investors, a private equity firm focused on healthcare therapeutics and medical devices, has raised $47.7 million for its first pooled fund. Also, it has secured an additional $15 million commitment, which will be released when the fund reaches its $100 million final target.

Venture fundraising tops $50 bln in 2018 for new 18-year record

On the Bleeding Edge: Year in Review shows an onslaught of fundraising

CPPIB to invest up to $1 bln in venture capital funds: report

Canada Pension Plan Investment Board (CPPIB) is planning to put $500 million to $1 billion to work in the venture capital market, according to a report by The Logic. The $368 billion pension fund is hiring a senior principal to focus on investments in the space, the report said. The investment pro will be responsible for committing capital to 10 to 15 venture capital funds in North America and Europe. CPPIB Managing Director Shane Feeney, who heads global private equity, told The Logic the pension fund could make investments "with more direct VC exposure" in the future. CPPIB joined the initial close of Northleaf Capital Partners' second Canadian venture capital fund of funds, announced this week.

SDVentures backs women's health startup Flo Health

Flo Health, a women’s health startup, has secured funding from SDVentures. No financial terms were disclosed.

Biotech startup Neuraptive Therapeutics seals $11.5 mln Series A

Neuraptive Therapeutics Inc, a biotech startup based in Colorado and Pennsylvania, has raised $11.5 million in Series A funding. New Rhein Healthcare Investors LLC led the round.

Swiss startup Scailyte reels in about $2.8 mln seed

Scailyte AG, a Swiss single-cell tech startup, has raised CHF 2.75 million (approximately $2.8 million) in seed funding. The investors were Swisscom Ventures and and Zürcher Kantonalbank..

Zigg Capital to raise $100 mln venture fund

Zigg Capital has set out to raise a $100 million venture-capital fund, according to a filing with the SEC.

The rise of unicorns: a funding event, not a destination

Pandion Therapeutics lands funding

Cambridge, Massachusetts-based Pandion Therapeutics, a biotech company focused on treating autoimmune and inflammatory disease, has secured an undisclosed amount of funding. The investor was JDRF T1D Fund.